| 000 | 01268 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250516012711.0 | ||
| 264 | 0 | _c20110203 | |
| 008 | 201102s 0 0 jpn d | ||
| 022 | _a0385-2385 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMitarai, Tetsuya | |
| 245 | 0 | 0 |
_a[Immunosuppressive therapies for refractory nephrotic syndrome]. _h[electronic resource] |
| 260 |
_bNihon Jinzo Gakkai shi _c2010 |
||
| 300 |
_a924-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAntibodies, Monoclonal, Murine-Derived _xadministration & dosage |
| 650 | 0 | 4 |
_aAzathioprine _xadministration & dosage |
| 650 | 0 | 4 |
_aCyclophosphamide _xadministration & dosage |
| 650 | 0 | 4 |
_aCyclosporine _xadministration & dosage |
| 650 | 0 | 4 |
_aCytochrome P-450 Enzyme System _xgenetics |
| 650 | 0 | 4 | _aDrug Monitoring |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aMycophenolic Acid _xadministration & dosage |
| 650 | 0 | 4 |
_aNephrotic Syndrome _xdrug therapy |
| 650 | 0 | 4 | _aPolymorphism, Genetic |
| 650 | 0 | 4 |
_aRibonucleosides _xadministration & dosage |
| 650 | 0 | 4 | _aRituximab |
| 650 | 0 | 4 |
_aTacrolimus _xadministration & dosage |
| 773 | 0 |
_tNihon Jinzo Gakkai shi _gvol. 52 _gno. 7 _gp. 924-7 |
|
| 999 |
_c20374703 _d20374703 |
||